Crossmark

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis

Published Online: 2021-09-29

Published Print: 2021-12

Authors

Wumaier, Kaidireyahan

Li, Wenqian

Chen, Naifei

Cui, Jiuwei https://orcid.org/0000-0001-6496-7550
License Information

Text and Data Mining valid from 2021-09-29

Version of Record valid from 2021-09-29
More Information

Article History

Received: 23 July 2021

Accepted: 5 September 2021

First Online: 29 September 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current